Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2868)
- Probing a distinct druggable tubulin binding site with gatorbulins 1-7, their metabolic and physicochemical properties, and pharmacological consequences. (2023/10/21) ♡
- Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study. (2023/10/19) ♡
- Compliance with the EAT-Lancet diet and risk of colorectal cancer: a prospective cohort study in 98,415 American adults. (2023/10/19) ♡
- Prehabilitation in an Integrative Medicine Day Clinic for Patients Undergoing Neoadjuvant Treatment: Single-Center Feasibility Pilot Study. (2023/10/18) ♡
- miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression. (2023/10/16) ♡
- Dietary inflammatory index and renal cancer risk: a prospective study. (2023/10/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [DICER1 syndrome: clinical variety endocrine manifestations and features of diagnostics]. (2023/10/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Incidental discovery of primary peritoneal psammocarcinoma. (2023/10/16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development and validation of a predictive model of abnormal uterine bleeding associated with ovulatory dysfunction: a case-control study. (2023/10/12) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Evidence-based guideline: unexplained infertility†. (2023/10/03) ♡
- Genetic and Functional Modifications Associated with Ovarian Cancer Cell Aggregation and Limited Culture Conditions. (2023/10/03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study). (2023/10/02) ♡
- Association of diabetes risk reduction diet with renal cancer risk in 101,755 participants: a prospective study. (2023/10/02) ♡
- Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer. (2023/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mediterranean diet and olive oil, microbiota, and obesity-related cancers. From mechanisms to prevention. (2023/10/01) ♡
- Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older. (2023/10/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. A metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate. (2023/10/01) ♡
- Dairy product consumption and lung cancer risk: A prospective analysis. (2023/10/01) ♡
- Latin American and the Caribbean Code Against Cancer 1st edition: Weight, physical activity, diet, breastfeeding, and cancer. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. ELTD1 Review: New Regulator of Angiogenesis in Glioma. (2023/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Resistance Improvement and Sensitivity Enhancement of Cancer Therapy by a Novel Antitumor Candidate onto A2780 CP and A2780 S Cell Lines. (2023/10/01) ♡
- Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer. (2023/10/01) ♡
- Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation. (2023/09/29) ♡
- Adherence to diabetes risk reduction diet and the risk of head and neck cancer: a prospective study of 101,755 American adults. (2023/09/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Association between anogenital distance as a noninvasive index in the diagnosis and prognosis of reproductive disorder: A systematic review. (2023/09/20) ♡
- Maternal and paternal obesity differentially reprogram the ovarian mitochondrial biogenesis of F1 female rats. (2023/09/19) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Unkeito promotes follicle development by restoring reduced follicle-stimulating hormone responsiveness in rats with polycystic ovary syndrome. (2023/09/18) ♡
- Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses. (2023/09/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dietary fats and serum lipids in relation to the risk of ovarian cancer: a meta-analysis of observational studies. (2023/09/14) ♡
- Impact of resection for ovarian metastases from colorectal cancer and clinicopathologic analysis: A multicenter retrospective study in Japan. (2023/09/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prevalence of propionic acidemia in China. (2023/09/09) ♡
- Comparison of Antioxidant and Antiproliferative Effects of Various Forms of Garlic and Ramsons. (2023/09/08) ♡
- Nuclear β-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma. (2023/09/01) ♡
- Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas. (2023/09/01) ♡
- Risk of epithelial ovarian tumors among women with polycystic ovary syndrome: A nationwide population-based cohort study. (2023/09/01) ♡
- Orotic acid induces apoptotic death in ovarian adult granulosa tumour cells and increases mitochondrial activity in normal ovarian granulosa cells. (2023/09/01) ♡
- Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models. (2023/09/01) ♡
- Long-term cancer outcomes after bariatric surgery. (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MicroRNA and gynecological cancers: Focus on miR-195. (2023/09/01) ♡
- Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001-2018. (2023/09/01) ♡
- Fabricating a low-temperature synthesized graphene-cellulose acetate-sodium alginate scaffold for the generation of ovarian cancer spheriod and its drug assessment. (2023/09/01) ♡
- Exploratory profiles of phenols, parabens, and per- and poly-fluoroalkyl substances among NHANES study participants in association with previous cancer diagnoses. (2023/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Immature Teratoma in Pregnancy: A Case Report. (2023/09/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria. (2023/09/01) ♡
- MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells. (2023/08/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Breastfeeding-Related Health Benefits in Children and Mothers: Vital Organs Perspective. (2023/08/25) ♡
- Radiation Effects on the Fetus. (2023/08/23) ♡
- AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis. (2023/08/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.